Oxidative stress in graves' disease

Area of Science:

• Endocrinology and Metabolism
• Immunology
• Oxidative Stress Research

Background:

• Reactive oxygen species (ROS) and oxidative damage are linked to autoimmune diseases like Graves' disease.
• Graves' disease, an autoimmune disorder, causes hyperthyroidism and potentially orbitopathy, both associated with increased oxidative stress.

Purpose of the Study:

• To investigate the role of oxidative stress in Graves' disease pathogenesis and clinical manifestations.
• To evaluate the therapeutic potential of antioxidants in managing hyperthyroidism and Graves' orbitopathy.

Main Methods:

• Review of existing human and animal studies examining oxidative stress parameters in Graves' disease.
• Analysis of the effects of antithyroid drugs and antioxidant supplementation on disease markers and clinical outcomes.
• Consideration of findings from a large randomized clinical trial on selenium supplementation for Graves' orbitopathy.

Main Results:

• Untreated hyperthyroidism correlates with elevated oxidative stress markers and, often, increased antioxidant enzymes.
• Achieving euthyroidism with antithyroid drugs reverses oxidative stress abnormalities.
• Antioxidants show potential in improving hyperthyroidism symptoms and, combined with drugs, accelerate euthyroidism; selenium benefits mild Graves' orbitopathy.

Conclusions:

• Increased ROS generation contributes to Graves' disease pathophysiology, including orbitopathy.
• Antioxidant therapy, particularly selenium, offers a promising adjunctive treatment for Graves' disease and its complications.